Skip to main content

Persistent Asset Partners Ltd

Position in NVO — Novo Nordisk A S

CIK 2056052 HONG KONG, K3

Position in NVO

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$1,227,264
+$1,091,841 QoQ
Shares Held
25,600
+594.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#477
of 1,348 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Derivatives in NVO

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$6,855
PutShares
143

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Persistent Asset Partners Ltd holds $4,144,035 across 7 Drug Manufacturers - General names. NVO ranks #2 (29.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NVO
Novo Nordisk A S
This page
25,600 $1,227,264

All Filings in NVO

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,227,264 25,600
2026-06-30 $6,855 143
2026-03-31 $5,255 143
2026-03-31 $135,423 3,685
2025-09-30 $319,566 5,759
2025-03-31 $15,971 230
2025-03-31 $406,848 5,859
2024-12-31 $34,713 536
2024-12-31 $19,817 490